Clinical Trial Update: Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics [NA]

View source ↗

Summary

A completed trial evaluated flaxseed in combination with aromatase inhibitors and its effect on breast tumor characteristics. The results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)
• Letrozole (letrozole)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2017-08-16